Systemic Anti-Cancer Therapy Regimen Library
BR Metastatic - alpelisib and fulvestrant
Treatment Overview
Cycle 1 - 28 days - fulvestrant loading dose
Cycle 2 (and all further cycles) - 28 days
Cycle details
Cycle 1 - 28 days - fulvestrant loading dose
| Medication | Dose | Route | Days | Max Duration |
|---|---|---|---|---|
| loratadine | 10 mg Once daily | oral administration | 0 | |
| alpelisib | 300 mg Once daily | oral administration | 1 to 28 | |
| fulvestrant | 500 mg | intramuscular injection | 1, 15 | |
| loperamide | 2 mg | oral administration | 1 |
Cycle 2 (and all further cycles) - 28 days
| Medication | Dose | Route | Days | Max Duration |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration | 1 to 28 | |
| fulvestrant | 500 mg | intramuscular injection | 1 | |
| loratadine | 10 mg Once daily | oral administration | 1 |
Full details
Cycle 1 - 28 days - fulvestrant loading dose
Day: 0
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| loratadine | 10 mg Once daily | oral administration |
Instructions:
Commence taking the day before alpelisib and continue for 4 weeks or as per institutional policy. If no rash develops after 4 weeks, consider taking only when required to manage symptoms of rash. |
Day: 1
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
|
| fulvestrant | 500 mg | intramuscular injection |
Instructions:
|
|
| loperamide | 2 mg | oral administration |
Instructions:
Take TWO capsules (=4 mg) at onset of loose bowel motions and a further ONE capsule (=2 mg) for every loose bowel motion (maximum of EIGHT capsules in 24 hours), or use as directed by oncologist or haematologist. |
Day: 2
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 3
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 4
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 5
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 6
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 7
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 8
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 9
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 10
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 11
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 12
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 13
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 14
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 15
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
|
| fulvestrant | 500 mg | intramuscular injection |
Instructions:
|
Day: 16
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 17
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 18
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 19
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 20
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 21
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 22
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 23
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 24
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 25
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 26
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 27
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 28
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Cycle 2 (and all further cycles) - 28 days
Day: 1
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
|
| fulvestrant | 500 mg | intramuscular injection |
Instructions:
|
|
| loratadine | 10 mg Once daily | oral administration |
Instructions:
When required to manage symptoms of rash, or as per institutional policy. |
Day: 2
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 3
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 4
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 5
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 6
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 7
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 8
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 9
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 10
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 11
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 12
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 13
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 14
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 15
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 16
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 17
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 18
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 19
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 20
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 21
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 22
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 23
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 24
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 25
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 26
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 27
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Day: 28
| Medication | Dose | Route | Max duration | Details |
|---|---|---|---|---|
| alpelisib | 300 mg Once daily | oral administration |
Instructions:
|
Supportive Care Factors
| Factor | Value |
|---|---|
| Diarrhoea risk: | Anti-diarrhoeals are usually prescribed with this treatment |
| Emetogenicity: | Minimal to low |
Emetogenicity: Antiemetics may be required with continuous dosing of oral anti-cancer medicines with MINIMAL to LOW emetic risk; an individualised approach is appropriate.
References
AstraZeneca Limited. Faslodex New Zealand Data Sheet 16 July 2020. https://www.medsafe.govt.nz/profs/datasheet/f/faslodexinj.pdf (Accessed 27 May 2025).
Novartis Pharmaceuticals Australia Pty Limited. Alpelisib Australian Data Sheet 20 March 2020. https://www.tga.gov.au/sites/default/files/auspar-alpelisib-200820-pi.pdf (Accessed 27 May 2025).
* The medicines, doses, combinations, and schedule in this treatment regimen have been carefully reviewed against international best practice guidelines by specialists in medical oncology around New Zealand and this advice has been accepted for publication by Te Aho o Te Kahu (the Cancer Control Agency). Sometimes medicines that are used in routine clinical practice have not been through a formal review process by the NZ Medicines Regulator Medsafe and are therefore considered unapproved or off-label. These medicines are legally able to be prescribed through sections 25 and 29 of the Medicines Act and by obtaining informed consent from patients. All treatment regimens listed on this website have been through robust peer review and are considered an accepted standard of care, whether prescribed through sections 25 or 29 or carrying formal Medsafe Approval.
s29: This symbol indicates that some formulations of the associated medicine are legally only able to be prescribed under section 29 of the Medicines Act. You can see which formulations are section 29 by hovering over the s29 symbol. You can access full medication details from the New Zealand Formulary by clicking on the medication name. Each clinician retains full responsibility for ensuring they have complied with all relevant obligations and requirements of section 29 including obtaining informed patient consent prior to prescribing the applicable medicine.

